Table 5 SBI, 10 years—Description and comparison with the 1st examination (period 0 = Baseline). Number of implants (n)
| Â | Â | Â | Â | Â | Comparison with Baseline* | ||
|---|---|---|---|---|---|---|---|
Period | n | 0 | 1 | 2 | Coeff | 95%-KI | p value |
Baseline | 61 | 33 (54.1%) | 24 (39.3%) | 4 (6.6%) | – | – | – |
  ≤1 Y | 61 | 27 (44.3%) | 30 (49.2%) | 4 (6.6%) | 0.43 | − 0.12–0.99 | 0.125 |
  ≤2 Y | 36 | 11 (30.6%) | 20 (55.6%) | 5 (13.9%) | 1.16 | 0.49–1.84 | 0.001 |
  ≤3 Y | 39 | 10 (25.6%) | 24 (61.5%) | 5 (12.8%) | 1.21 | 0.55–1.87 |  < 0.001 |
  ≤4 Y | 31 | 12 (38.7%) | 19 (61.3%) | 0 (0%) | 0.82 | 0.13–1.51 | 0.020 |
  ≤5 Y | 34 | 10 (29.4%) | 23 (67.6%) | 1 (2.9%) | 1.08 | 0.41–1.75 | 0.002 |
  ≤6 Y | 23 | 10 (43.5%) | 13 (56.5%) | 0 (0%) | 0.67 | − 0.10–1.45 | 0.086 |
  ≤7 Y | 22 | 15 (68.2%) | 7 (31.8%) | 0 (0%) | − 0.01 | − 0.84–0.82 | 0.977 |
  ≤8 Y | 20 | 4 (20.0%) | 16 (80.0%) | 0 (0%) | 1.63 | 0.80–2.47 |  < 0.001 |
  ≤9 Y | 17 | 7 (41.2%) | 10 (58.8%) | 0 (0%) | 0.89 | 0.05–1.73 | 0.039 |
  ≤10 Y | 17 | 7 (41.2%) | 10 (58.8%) | 0 (0%) | 1.02 | 0.17–1.87 | 0.018 |